San Diego Union-Tribune
Mass. Biotechnology company Momenta Pharmaceuticals Inc. says the U.S. Food and Drug Administration has approved its generic version of the Sanofi-Aventis SA injected blood thinner Lovenox. Shares of Momenta soared $9.77, or 82 percent, to close...
The Motley Fool
The Cambridge, MA-based biotech company said today that the FDA has approved a generic version of a common anti-clotting drug developed by Momenta and Sandoz, a unit of Novartis . The news sent Momenta stock rocketing up 77 percent by noon Eastern...